Page
%P
-
Article
A transcriptomic model for homologous recombination deficiency in prostate cancer
Tumors with mutations associated with homologous recombination deficiency (HRD) are uncommon in prostate cancer (PCa) and variably responsive to PARP inhibition. To better identify tumors with HRD, we develope...